Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., Duke University School of Medicine 1973
• Research
• 

  Selected Grants

  • "A Phase 3, Randomized Open-label Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castrationresistant Prostate Cancer (mCRPC) Who are Unselected for Homologous Recombination Re awarded by Merck 2019 - 2024
  • A multinational, phase 3, randomized, double-blind, placebo-controlled, efficacy and safety study of enzalutamide in patients with nonmetastatic castration-resistant prostate cancer awarded by Medivation, Inc. 2014 - 2022
  • Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365) awarded by Merck 2017 - 2022
  • A randomized phase 3 study comparing cabazitaxel/prednisone in combination with Custirsen (OGX-011) to cabazitaxel/prednisone for second-line chemotherapy in men with metastatic castrate resistant prostate cancer awarded by OncoGenex 2014 - 2019
  • A randomized, open-label, phase 2 study of sipuleucel-t with concurrent versus swquential administration of enzalutamide in men with metastatic castrate-resistant prostate cancer awarded by Dendreon Corporation 2014 - 2019
  • An open label, phase 1/2 safety, pharmacokinetic, and proof-of-concept study of ARN-509 in patients with progressive awarded by Aragon Pharmaceuticals, Inc 2014 - 2017
  • A Phase 1/2 Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Once-Daily VT-464 in Patients with Castration-Resistant Prostate Cancer awarded by Innocrin Pharmaceutical, Inc. 2014 - 2017
• 

  External Relationships

  • AstraZeneca
  • Blue Earth Diagnostics
  • Dendreon Corporation
  • Merck Sharpe & Dohme (Merck & Co, USA)
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Weiseth, Amber, Avery Plough, Reena Aggarwal, Grace Galvin, Amber Rucker, Natalie Henrich, Kate Miller, et al. “Improving communication and teamwork during labor: A feasibility, acceptability, and safety study.” Birth 49, no. 4 (December 2022): 637–47. https://doi.org/10.1111/birt.12630.
       Full Text  Link to Item
    • Aggarwal, Reena, Avery Plough, Natalie Henrich, Grace Galvin, Amber Rucker, Chris Barnes, William Berry, Toni Golen, and Neel T. Shah. “The design of "TeamBirth": A care process to improve communication and teamwork during labor.” Birth 48, no. 4 (December 2021): 534–40. https://doi.org/10.1111/birt.12566.
       Full Text  Link to Item
    • Lagoo, Janaka, William Berry, Natalie Henrich, Atul Gawande, Luke Sato, and Susan Haas. “Safely Practicing in a New Environment: A Qualitative Study to Inform Physician Onboarding Practices.” Joint Commission Journal on Quality and Patient Safety 46, no. 6 (June 2020): 314–20. https://doi.org/10.1016/j.jcjq.2020.03.002.
       Full Text
    • Solsky, Ian, William Berry, Lizabeth Edmondson, Janaka Lagoo, Joshua Baugh, Alex Blair, Sara Singer, and Alex B. Haynes. “World Health Organization Surgical Safety Checklist Modification: Do Changes Emphasize Communication and Teamwork?” J Surg Res 246 (February 2020): 614–22. https://doi.org/10.1016/j.jss.2018.09.035.
       Full Text  Link to Item
    • Lagoo, Janaka, Robbie Singal, William Berry, Atul Gawande, Christine Lim, Sompob Paibulsirijit, and Joaquim Havens. “Development and Feasibility Testing of a Device Briefing Tool and Training to Improve Patient Safety During Introduction of New Devices in Operating Rooms: Best Practices and Lessons Learned.” J Surg Res 244 (December 2019): 579–86. https://doi.org/10.1016/j.jss.2019.05.056.
       Full Text  Link to Item
    • Tucker, Matthew D., Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, et al. “Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer.” Cancer Med 8, no. 10 (August 2019): 4644–55. https://doi.org/10.1002/cam4.2375.
       Full Text  Link to Item
    • Lagoo, Janaka, William R. Berry, Kate Miller, Brandon J. Neal, Luke Sato, Keith D. Lillemoe, Gerard M. Doherty, et al. “Multisource Evaluation of Surgeon Behavior Is Associated With Malpractice Claims.” Ann Surg 270, no. 1 (July 2019): 84–90. https://doi.org/10.1097/SLA.0000000000002742.
       Full Text  Link to Item
    • Armstrong, Andrew J., Susan Halabi, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, et al. “Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.” J Clin Oncol 37, no. 13 (May 1, 2019): 1120–29. https://doi.org/10.1200/JCO.18.01731.
       Full Text  Link to Item
    • Petrylak, Daniel P., Philip Kantoff, Nicholas J. Vogelzang, Anthony Mega, Mark T. Fleming, Joe J. Stephenson, Richard Frank, et al. “Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.” Prostate 79, no. 6 (May 2019): 604–13. https://doi.org/10.1002/pros.23765.
       Full Text  Link to Item
    • Berry, William R., Lizabeth Edmondson, Lorri R. Gibbons, Ashley Kay Childers, Alex B. Haynes, Richard Foster, Sara J. Singer, and Atul A. Gawande. “Scaling Safety: The South Carolina Surgical Safety Checklist Experience.” Health Aff (Millwood) 37, no. 11 (November 2018): 1779–86. https://doi.org/10.1377/hlthaff.2018.0717.
       Full Text  Link to Item
    • Gupta, Shilpa, Luke T. Nordquist, Mark T. Fleming, William R. Berry, Jingsong Zhang, Sharon L. Ervin, Joel R. Eisner, Edwina S. Baskin-Bey, and Neal D. Shore. “Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer.” Clin Cancer Res 24, no. 21 (November 1, 2018): 5225–32. https://doi.org/10.1158/1078-0432.CCR-18-0564.
       Full Text  Link to Item
    • Columbus, Alexandra B., Manuel Castillo-Angeles, William R. Berry, Adil H. Haider, Ali Salim, and Joaquim M. Havens. “An evidence-based intraoperative communication tool for emergency general surgery: a pilot study.” The Journal of Surgical Research 228 (August 2018): 281–89. https://doi.org/10.1016/j.jss.2018.03.007.
       Full Text
    • Forrester, Jared A., Luca A. Koritsanszky, Demisew Amenu, Alex B. Haynes, William R. Berry, Seifu Alemu, Fekadu Jiru, and Thomas G. Weiser. “Developing Process Maps as a Tool for a Surgical Infection Prevention Quality Improvement Initiative in Resource-Constrained Settings.” J Am Coll Surg 226, no. 6 (June 2018): 1103-1116.e3. https://doi.org/10.1016/j.jamcollsurg.2018.03.020.
       Full Text  Link to Item
    • Brindle, Mary E., Natalie Henrich, Andrew Foster, Stanley Marks, Michael Rose, Robert Welsh, and William Berry. “Implementation of surgical debriefing programs in large health systems: an exploratory qualitative analysis.” Bmc Health Serv Res 18, no. 1 (March 27, 2018): 210. https://doi.org/10.1186/s12913-018-3003-3.
       Full Text  Link to Item
    • Alidina, Shehnaz, Sara N. Goldhaber-Fiebert, Alexander A. Hannenberg, David L. Hepner, Sara J. Singer, Bridget A. Neville, James R. Sachetta, Stuart R. Lipsitz, and William R. Berry. “Factors associated with the use of cognitive aids in operating room crises: a cross-sectional study of US hospitals and ambulatory surgical centers.” Implement Sci 13, no. 1 (March 26, 2018): 50. https://doi.org/10.1186/s13012-018-0739-4.
       Full Text  Link to Item
    • Haynes, Alex B., Lizabeth Edmondson, Stuart R. Lipsitz, George Molina, Bridget A. Neville, Sara J. Singer, Aunyika T. Moonan, et al. “Mortality Trends After a Voluntary Checklist-based Surgical Safety Collaborative.” Ann Surg 266, no. 6 (December 2017): 923–29. https://doi.org/10.1097/SLA.0000000000002249.
       Full Text  Link to Item
    • Molina, George, William R. Berry, Stuart R. Lipsitz, Lizabeth Edmondson, Zhonghe Li, Bridget A. Neville, Aunyika T. Moonan, et al. “Perception of Safety of Surgical Practice Among Operating Room Personnel From Survey Data Is Associated With All-cause 30-day Postoperative Death Rate in South Carolina.” Ann Surg 266, no. 4 (October 2017): 658–66. https://doi.org/10.1097/SLA.0000000000002378.
       Full Text  Link to Item
    • Molina, G., R. Singal, A. B. Haynes, V. Mahishi, K. K. Davis, G. Foster, M. A. Miller, et al. “Perception of safety of surgical practice among healthcare professionals who work in an operating room in ambulatory surgery centers in the United States: A retrospective analysis of survey data.” Perioperative Care and Operating Room Management 8 (September 1, 2017): 12–18. https://doi.org/10.1016/j.pcorm.2017.07.002.
       Full Text
    • Rathkopf, D. E., M. R. Smith, C. J. Ryan, W. R. Berry, N. D. Shore, G. Liu, C. S. Higano, et al. “Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.” Ann Oncol 28, no. 9 (September 1, 2017): 2264–71. https://doi.org/10.1093/annonc/mdx283.
       Full Text  Link to Item
    • Hepner, David L., Alexander F. Arriaga, Jeffrey B. Cooper, Sara N. Goldhaber-Fiebert, David M. Gaba, William R. Berry, Daniel J. Boorman, and Angela M. Bader. “Operating Room Crisis Checklists and Emergency Manuals.” Anesthesiology 127, no. 2 (August 2017): 384–92. https://doi.org/10.1097/ALN.0000000000001731.
       Full Text  Link to Item
    • Plough, Avery C., Grace Galvin, Zhonghe Li, Stuart R. Lipsitz, Shehnaz Alidina, Natalie J. Henrich, Lisa R. Hirschhorn, et al. “Relationship Between Labor and Delivery Unit Management Practices and Maternal Outcomes.” Obstet Gynecol 130, no. 2 (August 2017): 358–65. https://doi.org/10.1097/AOG.0000000000002128.
       Full Text  Link to Item
    • Alidina, Shehnaz, Hye-Chun Hur, William R. Berry, George Molina, Guy Guenthner, Anna M. Modest, and Sara J. Singer. “Narrative feedback from OR personnel about the safety of their surgical practice before and after a surgical safety checklist intervention.” Int J Qual Health Care 29, no. 4 (August 1, 2017): 461–69. https://doi.org/10.1093/intqhc/mzx050.
       Full Text  Link to Item
    • Brindle, Mary E., Derek J. Roberts, Oluwatomilayo Daodu, Alex Bernard Haynes, Christy Cauley, Elijah Dixon, Claude La Flamme, Paul Bain, and William Berry. “Deriving literature-based benchmarks for surgical complications in high-income countries: a protocol for a systematic review and meta-analysis.” Bmj Open 7, no. 5 (May 9, 2017): e013780. https://doi.org/10.1136/bmjopen-2016-013780.
       Full Text  Link to Item
    • Lashoher, Angela, Eric B. Schneider, Catherine Juillard, Kent Stevens, Elizabeth Colantuoni, William R. Berry, Christina Bloem, et al. “Implementation of the World Health Organization Trauma Care Checklist Program in 11 Centers Across Multiple Economic Strata: Effect on Care Process Measures.” World J Surg 41, no. 4 (April 2017): 954–62. https://doi.org/10.1007/s00268-016-3759-8.
       Full Text  Link to Item
    • Vogelzang, Nicholas J., Karim Fizazi, John M. Burke, Ronald De Wit, Joaquim Bellmunt, Thomas E. Hutson, Edward Crane, et al. “Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer.” Eur Urol 71, no. 2 (February 2017): 168–71. https://doi.org/10.1016/j.eururo.2016.07.051.
       Full Text  Link to Item
    • Duclos, A., J. L. Peix, V. Piriou, P. Occelli, A. Denis, S. Bourdy, M. J. Carty, et al. “Cluster randomized trial to evaluate the impact of team training on surgical outcomes.” Br J Surg 103, no. 13 (December 2016): 1804–14. https://doi.org/10.1002/bjs.10295.
       Full Text  Link to Item
    • Smith, Matthew R., Emmanuel S. Antonarakis, Charles J. Ryan, William R. Berry, Neal D. Shore, Glenn Liu, Joshi J. Alumkal, et al. “Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort.” Eur Urol 70, no. 6 (December 2016): 963–70. https://doi.org/10.1016/j.eururo.2016.04.023.
       Full Text  Link to Item
    • Molina, George, Bridget A. Neville, Stuart R. Lipsitz, Lorri Gibbons, Ashley Kay Childers, Atul A. Gawande, William R. Berry, and Alex B. Haynes. “Postoperative acute care use after freestanding ambulatory surgery.” J Surg Res 205, no. 2 (October 2016): 331–40. https://doi.org/10.1016/j.jss.2016.06.084.
       Full Text  Link to Item
    • Wong, Judith M., William R. G. Perry, Yelena Greenberg, Allen L. Ho, Stuart R. Lipsitz, Liliana C. Goumnerova, Edward R. Laws, William R. Berry, Atul A. Gawande, and Angela M. Bader. “Integrating Cerebrospinal Fluid Shunt Quality Checks into the World Health Organization's Safe Surgery Checklist: A Pilot Study.” World Neurosurg 92 (August 2016): 491-498.e3. https://doi.org/10.1016/j.wneu.2016.06.064.
       Full Text  Link to Item
    • Berry, William, Alex Haynes, and Janaka Lagoo. “The Surgical Checklist: It Cannot Work If You Do Not Use It.” Jama Surg 151, no. 7 (July 1, 2016): 647. https://doi.org/10.1001/jamasurg.2015.5551.
       Full Text  Link to Item
    • Molina, George, Wei Jiang, Lizabeth Edmondson, Lorri Gibbons, Lyen C. Huang, Mathew V. Kiang, Alex B. Haynes, Atul A. Gawande, William R. Berry, and Sara J. Singer. “Implementation of the Surgical Safety Checklist in South Carolina Hospitals Is Associated with Improvement in Perceived Perioperative Safety.” J Am Coll Surg 222, no. 5 (May 2016): 725-736.e5. https://doi.org/10.1016/j.jamcollsurg.2015.12.052.
       Full Text  Link to Item
    • Weiser, Thomas G., Alex B. Haynes, George Molina, Stuart R. Lipsitz, Micaela M. Esquivel, Tarsicio Uribe-Leitz, Rui Fu, et al. “Size and distribution of the global volume of surgery in 2012.” Bull World Health Organ 94, no. 3 (March 1, 2016): 201-209F. https://doi.org/10.2471/BLT.15.159293.
       Full Text  Link to Item
    • Molina, George, Thomas G. Weiser, Stuart R. Lipsitz, Micaela M. Esquivel, Tarsicio Uribe-Leitz, Tej Azad, Neel Shah, et al. “Relationship Between Cesarean Delivery Rate and Maternal and Neonatal Mortality.” Jama 314, no. 21 (December 1, 2015): 2263–70. https://doi.org/10.1001/jama.2015.15553.
       Full Text  Link to Item
    • McNamara, Megan, and William Berry. “Complete Biochemical Response (Prostate Specific Antigen) to Sipuleucel-T in Metastatic Castrate-Resistant Prostate Cancer: A Case Report With Docetaxel Chemotherapy Administered Just Before Sipuleucel-T.” Clin Genitourin Cancer 13, no. 5 (October 2015): e361–64. https://doi.org/10.1016/j.clgc.2015.02.004.
       Full Text  Link to Item
    • Nurudeen, Suliat M., Gifty Kwakye, William R. Berry, Elliot L. Chaikof, Keith D. Lillemoe, Frederick Millham, Marc Rubin, et al. “Can 360-Degree Reviews Help Surgeons? Evaluation of Multisource Feedback for Surgeons in a Multi-Institutional Quality Improvement Project.” Journal of the American College of Surgeons 221, no. 4 (October 2015): 837–44. https://doi.org/10.1016/j.jamcollsurg.2015.06.017.
       Full Text
    • Singer, Sara J., Wei Jiang, Lyen C. Huang, Lorri Gibbons, Mathew V. Kiang, Lizabeth Edmondson, Atul A. Gawande, and William R. Berry. “Surgical team member assessment of the safety of surgery practice in 38 South Carolina hospitals.” Med Care Res Rev 72, no. 3 (June 2015): 298–323. https://doi.org/10.1177/1077558715577479.
       Full Text  Link to Item
    • Joshua, Anthony M., Neal D. Shore, Fred Saad, Kim N. Chi, Carl A. Olsson, Urban Emmenegger, Mark Scholz, et al. “Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.” Prostate 75, no. 8 (June 2015): 836–44. https://doi.org/10.1002/pros.22965.
       Full Text  Link to Item
    • Haynes, Alex B., William R. Berry, and Atul A. Gawande. “What do we know about the safe surgery checklist now?” Ann Surg 261, no. 5 (May 2015): 829–30. https://doi.org/10.1097/SLA.0000000000001144.
       Full Text  Link to Item
    • Kim, Rebecca Y., Gifty Kwakye, Alvin C. Kwok, Ruslan Baltaga, Gheorghe Ciobanu, Alan F. Merry, Luke M. Funk, et al. “Sustainability and long-term effectiveness of the WHO surgical safety checklist combined with pulse oximetry in a resource-limited setting: two-year update from Moldova.” Jama Surg 150, no. 5 (May 2015): 473–79. https://doi.org/10.1001/jamasurg.2014.3848.
       Full Text  Link to Item
    • Huang, Lyen C., Dante Conley, Stu Lipsitz, Christopher C. Wright, Thomas W. Diller, Lizabeth Edmondson, William R. Berry, and Sara J. Singer. “The Surgical Safety Checklist and Teamwork Coaching Tools: a study of inter-rater reliability.” Bmj Qual Saf 23, no. 8 (August 2014): 639–50. https://doi.org/10.1136/bmjqs-2013-002446.
       Full Text  Link to Item
    • Haynes, Alex B., William R. Berry, and Atul A. Gawande. “Surgical safety checklists in ontario, Canada.” N Engl J Med 370, no. 24 (June 12, 2014): 2350. https://doi.org/10.1056/NEJMc1404583.
       Full Text  Link to Item
    • Finch, L. C., R. Y. Kim, S. Ttendo, J. K. Kiwanuka, I. A. Walker, I. H. Wilson, T. G. Weiser, W. R. Berry, and A. A. Gawande. “Evaluation of a large-scale donation of Lifebox pulse oximeters to non-physician anaesthetists in Uganda.” Anaesthesia 69, no. 5 (May 2014): 445–51. https://doi.org/10.1111/anae.12632.
       Full Text  Link to Item
    • McCrum, Marta L., Stuart R. Lipsitz, William R. Berry, Ashish K. Jha, and Atul A. Gawande. “Beyond volume: does hospital complexity matter?: an analysis of inpatient surgical mortality in the United States.” Med Care 52, no. 3 (March 2014): 235–42. https://doi.org/10.1097/MLR.0000000000000077.
       Full Text  Link to Item
    • Arriaga, Alexander F., Atul A. Gawande, Daniel B. Raemer, Daniel B. Jones, Douglas S. Smink, Peter Weinstock, Kathy Dwyer, et al. “Pilot testing of a model for insurer-driven, large-scale multicenter simulation training for operating room teams.” Ann Surg 259, no. 3 (March 2014): 403–10. https://doi.org/10.1097/SLA.0000000000000342.
       Full Text  Link to Item
    • Duclos, Antoine, Stéphanie Polazzi, Stuart R. Lipsitz, Sandrine Couray-Targe, Atul A. Gawande, Cyrille Colin, William Berry, John Z. Ayanian, and Matthew J. Carty. “Temporal variation in surgical mortality within French hospitals.” Med Care 51, no. 12 (December 2013): 1085–93. https://doi.org/10.1097/MLR.0b013e3182a97c54.
       Full Text  Link to Item
    • Niederberger, Craig. “Re: Pregnancy after varicocelectomy: impact of postoperative motility and DFI.” J Urol 190, no. 6 (December 2013): 2210. https://doi.org/10.1016/j.juro.2013.08.096.
       Full Text  Link to Item
    • Funk, Luke M., Dante M. Conley, William R. Berry, and Atul A. Gawande. “Hospital management practices and availability of surgery in sub-Saharan Africa: a pilot study of three hospitals.” World J Surg 37, no. 11 (November 2013): 2520–28. https://doi.org/10.1007/s00268-013-2172-9.
       Full Text  Link to Item
    • Arriaga, A. F., A. M. Bader, J. M. Wong, S. R. Lipsitz, W. R. Berry, J. E. Ziewacz, D. L. Hepner, et al. “Simulation-based trial of surgical-crisis checklists.” Obstetrical and Gynecological Survey 68, no. 5 (May 1, 2013): 336–38. https://doi.org/10.1097/01.ogx.0000430375.22369.87.
       Full Text
    • Eappen, Sunil, Bennett H. Lane, Barry Rosenberg, Stuart A. Lipsitz, David Sadoff, Dave Matheson, William R. Berry, Mark Lester, and Atul A. Gawande. “Relationship between occurrence of surgical complications and hospital finances.” Jama 309, no. 15 (April 17, 2013): 1599–1606. https://doi.org/10.1001/jama.2013.2773.
       Full Text  Link to Item
    • Kwok, Alvin C., Luke M. Funk, Ruslan Baltaga, Stuart R. Lipsitz, Alan F. Merry, Gerald Dziekan, Gheorghe Ciobanu, William R. Berry, and Atul A. Gawande. “Implementation of the World Health Organization surgical safety checklist, including introduction of pulse oximetry, in a resource-limited setting.” Ann Surg 257, no. 4 (April 2013): 633–39. https://doi.org/10.1097/SLA.0b013e3182777fa4.
       Full Text  Link to Item
    • Huang, Lyen, Rebecca Kim, and William Berry. “Creating a culture of safety by using checklists.” Aorn J 97, no. 3 (March 2013): 365–68. https://doi.org/10.1016/j.aorn.2012.12.019.
       Full Text  Link to Item
    • Weiser, Thomas G., and William R. Berry. “Review article: perioperative checklist methodologies.” Can J Anaesth 60, no. 2 (February 2013): 136–42. https://doi.org/10.1007/s12630-012-9854-x.
       Full Text  Link to Item
    • Arriaga, A. F., A. M. Bader, J. M. Wong, S. R. Lipsitz, W. R. Berry, J. E. Ziewacz, D. L. Hepner, et al. “Simulation-based trial of surgical-crisis checklists.” New England Journal of Medicine 368, no. 3 (January 17, 2013): 246–53. https://doi.org/10.1056/NEJMsa1204720.
       Full Text
    • Spector, J. M., A. Lashoher, P. Agrawal, C. Lemer, G. Dziekan, R. Bahl, M. Mathai, M. Merialdi, W. Berry, and A. A. Gawande. “Designing the WHO safe childbirth checklist program to improve quality of care at childbirth.” International Journal of Gynecology and Obstetrics 122, no. 2 (January 1, 2013): 164–68. https://doi.org/10.1016/j.ijgo.2013.03.022.
       Full Text
    • Taplin, Mary-Ellen, William R. Berry, Alison M. Casey, and Angel Aslo. “A urologic oncology roundtable discussion: issues to consider in choosing treatment for metastatic castration-resistant prostate cancer.” Hosp Pract (1995) 41, no. 4 (2013): 81–82. https://doi.org/10.3810/hp.2013.10.1084.
       Full Text  Link to Item
    • Pond, Gregory R., William R. Berry, Matthew D. Galsky, Brian A. Wood, Lance Leopold, and Guru Sonpavde. “Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer.” Clin Genitourin Cancer 10, no. 4 (December 2012): 239–45. https://doi.org/10.1016/j.clgc.2012.06.004.
       Full Text  Link to Item
    • Sonpavde, Guru, Gregory R. Pond, William R. Berry, Ronald de Wit, Andrew J. Armstrong, Mario A. Eisenberger, and Ian F. Tannock. “Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy.” Urol Oncol 30, no. 5 (September 2012): 607–13. https://doi.org/10.1016/j.urolonc.2010.07.002.
       Full Text  Link to Item
    • Arriaga, A. F., J. E. Ziewacz, A. M. Bader, J. M. Wong, W. R. Berry, D. L. Hepner, D. S. Smink, and A. A. Gawande. “Reply.” Journal of the American College of Surgeons 215, no. 2 (August 1, 2012): 303. https://doi.org/10.1016/j.jamcollsurg.2012.05.011.
       Full Text
    • Berry, W. R. “Erratum: Cardiac resuscitation in the operating room: Reflections on how we can do better (Canadian Journal of Anesthesia (2012) 59 (522-526) DOI: 10.1007/s12630-012-9697-5).” Canadian Journal of Anesthesia 59, no. 8 (August 1, 2012): 821. https://doi.org/10.1007/s12630-012-9743-3.
       Full Text
    • Ziewacz, J. E., A. F. Arriaga, A. M. Bader, W. R. Berry, L. Edmondson, J. M. Wong, S. R. Lipsitz, et al. “Erratum: Crisis checklists for the operating room: Development and pilot testing (Journal of the American College of Surgeons 213 (212-2173)).” Journal of the American College of Surgeons 215, no. 2 (August 1, 2012): 310. https://doi.org/10.1016/j.jamcollsurg.2012.05.012.
       Full Text
    • Stevens, Louis-Mathieu, Jeffrey B. Cooper, Daniel B. Raemer, Robert C. Schneider, Allan S. Frankel, William R. Berry, and Arvind K. Agnihotri. “Educational program in crisis management for cardiac surgery teams including high realism simulation.” J Thorac Cardiovasc Surg 144, no. 1 (July 2012): 17–24. https://doi.org/10.1016/j.jtcvs.2012.03.006.
       Full Text  Link to Item
    • Sonpavde, G., V. Matveev, J. M. Burke, J. R. Caton, M. T. Fleming, T. E. Hutson, M. D. Galsky, et al. “Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer.” Ann Oncol 23, no. 7 (July 2012): 1803–8. https://doi.org/10.1093/annonc/mdr555.
       Full Text  Link to Item
    • Berry, William R. “Cardiac resuscitation in the operating room: reflections on how we can do better.” Can J Anaesth 59, no. 6 (June 2012): 522–26. https://doi.org/10.1007/s12630-012-9697-5.
       Full Text  Link to Item
    • Fleming, Mark T., Guru Sonpavde, Michael Kolodziej, Sanjay Awasthi, Thomas E. Hutson, Danko Martincic, Ashutosh Rastogi, et al. “Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer.” Clin Genitourin Cancer 10, no. 1 (March 2012): 6–14. https://doi.org/10.1016/j.clgc.2011.11.003.
       Full Text  Link to Item
    • Pond, Gregory R., Andrew J. Armstrong, Brian A. Wood, Melissa Brookes, Lance Leopold, William R. Berry, Ronald de Wit, Mario A. Eisenberger, Ian F. Tannock, and Guru Sonpavde. “Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer.” Eur Urol 61, no. 2 (February 2012): 363–69. https://doi.org/10.1016/j.eururo.2011.06.034.
       Full Text  Link to Item
    • Arriaga, A. F., A. W. Elbardissi, S. E. Regenbogen, C. C. Greenberg, W. R. Berry, S. Lipsitz, D. Moorman, et al. “A policy-based intervention for the reduction of communication breakdowns in inpatient surgical care: Results from a harvard surgical safety collaborative.” Obstetrical and Gynecological Survey 66, no. 9 (September 1, 2011): 535–37. https://doi.org/10.1097/OGX.0b013e31823b6056.
       Full Text
    • Sonpavde, Guru, Gregory R. Pond, William R. Berry, Ronald de Wit, Mario A. Eisenberger, Ian F. Tannock, and Andrew J. Armstrong. “The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.” Cancer 117, no. 17 (September 1, 2011): 3963–71. https://doi.org/10.1002/cncr.25982.
       Full Text  Link to Item
    • Weiser, Thomas G., Marcus E. Semel, Alan E. Simon, Stuart R. Lipsitz, Alex B. Haynes, Luke M. Funk, William R. Berry, and Atul A. Gawande. “In-hospital death following inpatient surgical procedures in the United States, 1996-2006.” World Journal of Surgery 35, no. 9 (September 2011): 1950–56. https://doi.org/10.1007/s00268-011-1169-5.
       Full Text
    • Scher, Howard I., Xiaoyu Jia, Kim Chi, Ronald de Wit, William R. Berry, Peter Albers, Brian Henick, et al. “Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.” J Clin Oncol 29, no. 16 (June 1, 2011): 2191–98. https://doi.org/10.1200/JCO.2010.32.8815.
       Full Text  Link to Item
    • Pond, G. R., A. J. Armstrong, B. A. Wood, M. Brookes, L. H. Leopold, W. R. Berry, R. De Wit, M. A. Eisenberger, I. Tannock, and G. Sonpavde. “Evaluating the value of continuing docetaxel and prednisone (DP) beyond 10 cycles in men with metastatic castration-resistant prostate cancer (mCRPC).” J Clin Oncol 29, no. 15_suppl (May 20, 2011): 4582.
       Link to Item
    • Pond, G. R., A. J. Armstrong, B. A. Wood, M. Brookes, L. H. Leopold, W. R. Berry, R. De Wit, M. A. Eisenberger, I. Tannock, and G. Sonpavde. “Evaluating the value of continuing docetaxel and prednisone (DP) beyond 10 cycles in men with metastatic castration-resistant prostate cancer (mCRPC).” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 4582–4582. https://doi.org/10.1200/jco.2011.29.15_suppl.4582.
       Full Text
    • Arriaga, Alexander F., Andrew W. Elbardissi, Scott E. Regenbogen, Caprice C. Greenberg, William R. Berry, Stuart Lipsitz, Donald Moorman, et al. “A policy-based intervention for the reduction of communication breakdowns in inpatient surgical care: results from a Harvard surgical safety collaborative.” Ann Surg 253, no. 5 (May 2011): 849–54. https://doi.org/10.1097/SLA.0b013e3181f4dfc8.
       Full Text  Link to Item
    • Conley, Dante M., Sara J. Singer, Lizabeth Edmondson, William R. Berry, and Atul A. Gawande. “Effective surgical safety checklist implementation.” J Am Coll Surg 212, no. 5 (May 2011): 873–79. https://doi.org/10.1016/j.jamcollsurg.2011.01.052.
       Full Text  Link to Item
    • Funk, Luke M., Atul A. Gawande, Marcus E. Semel, Stuart R. Lipsitz, William R. Berry, Michael J. Zinner, and Ashish K. Jha. “Esophagectomy outcomes at low-volume hospitals: the association between systems characteristics and mortality.” Ann Surg 253, no. 5 (May 2011): 912–17. https://doi.org/10.1097/SLA.0b013e318213862f.
       Full Text  Link to Item
    • Haynes, Alex B., Scott E. Regenbogen, Thomas G. Weiser, Stuart R. Lipsitz, Gerald Dziekan, William R. Berry, and Atul A. Gawande. “Surgical outcome measurement for a global patient population: validation of the Surgical Apgar Score in 8 countries.” Surgery 149, no. 4 (April 2011): 519–24. https://doi.org/10.1016/j.surg.2010.10.019.
       Full Text  Link to Item
    • Sonpavde, G., G. R. Pond, W. R. Berry, R. De Wit, M. A. Eisenberger, I. Tannock, and A. J. Armstrong. “Association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.” J Clin Oncol 29, no. 7_suppl (March 2011): 118.
       Link to Item
    • Sonpavde, G., G. R. Pond, W. R. Berry, R. De Wit, M. A. Eisenberger, I. Tannock, and A. J. Armstrong. “Association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.” Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 118–118. https://doi.org/10.1200/jco.2011.29.7_suppl.118.
       Full Text
    • Ziewacz, J. E., A. F. Arriaga, A. M. Bader, W. R. Berry, L. Edmondson, J. M. Wong, S. R. Lipsitz, et al. “Crisis checklists for the operating room: Development and pilot testing.” Journal of the American College of Surgeons 213, no. 2 (January 1, 2011). https://doi.org/10.1016/j.jamcollsurg.2011.04.031.
       Full Text
    • Haynes, Alex B., Thomas G. Weiser, William R. Berry, Stuart R. Lipsitz, Abdel-Hadi S. Breizat, E Patchen Dellinger, Gerald Dziekan, et al. “Changes in safety attitude and relationship to decreased postoperative morbidity and mortality following implementation of a checklist-based surgical safety intervention.” Bmj Qual Saf 20, no. 1 (January 2011): 102–7. https://doi.org/10.1136/bmjqs.2009.040022.
       Full Text  Link to Item
    • Sonpavde, Guru, Ana M. Aparicio, Feng Zhan, Brittany North, Robert Delaune, Lawrence E. Garbo, Steven R. Rousey, et al. “Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer.” Urol Oncol 29, no. 6 (2011): 682–89. https://doi.org/10.1016/j.urolonc.2009.09.015.
       Full Text  Link to Item
    • Weiser, Thomas G., Alex B. Haynes, Angela Lashoher, Gerald Dziekan, Daniel J. Boorman, William R. Berry, and Atul A. Gawande. “Perspectives in quality: designing the WHO Surgical Safety Checklist.” Int J Qual Health Care 22, no. 5 (October 2010): 365–70. https://doi.org/10.1093/intqhc/mzq039.
       Full Text  Link to Item
    • Funk, Luke M., Thomas G. Weiser, William R. Berry, Stuart R. Lipsitz, Alan F. Merry, Angela C. Enright, Iain H. Wilson, Gerald Dziekan, and Atul A. Gawande. “Global operating theatre distribution and pulse oximetry supply: an estimation from reported data.” Lancet 376, no. 9746 (September 25, 2010): 1055–61. https://doi.org/10.1016/S0140-6736(10)60392-3.
       Full Text  Link to Item
    • Semel, Marcus E., Stephen Resch, Alex B. Haynes, Luke M. Funk, Angela Bader, William R. Berry, Thomas G. Weiser, and Atul A. Gawande. “Adopting a surgical safety checklist could save money and improve the quality of care in U.S. hospitals.” Health Aff (Millwood) 29, no. 9 (September 2010): 1593–99. https://doi.org/10.1377/hlthaff.2009.0709.
       Full Text  Link to Item
    • Arriaga, A. F., W. R. Berry, and A. A. Gawande. “Reply.” Annals of Surgery 252, no. 2 (August 1, 2010): 409–10. https://doi.org/10.1097/SLA.0b013e3181e9d97b.
       Full Text
    • Pond, G. R., G. Sonpavde, W. R. Berry, R. De Wit, A. J. Armstrong, M. A. Eisenberger, and I. Tannock. “Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 4637–4637. https://doi.org/10.1200/jco.2010.28.15_suppl.4637.
       Full Text
    • Weiser, Thomas G., Alex B. Haynes, Gerald Dziekan, William R. Berry, Stuart R. Lipsitz, Atul A. Gawande, and Atul A. Safe Surgery Saves Lives Investigators and Study Group. “Effect of a 19-item surgical safety checklist during urgent operations in a global patient population.” Ann Surg 251, no. 5 (May 2010): 976–80. https://doi.org/10.1097/SLA.0b013e3181d970e3.
       Full Text  Link to Item
    • Regan, M. M., E. K. O’Donnell, W. K. Kelly, S. Halabi, W. Berry, S. Urakami, N. Kikuno, and W. K. Oh. “Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.” Ann Oncol 21, no. 2 (February 2010): 312–18. https://doi.org/10.1093/annonc/mdp308.
       Full Text  Link to Item
    • Sonpavde, G., P. O. Periman, D. Bernold, D. Weckstein, M. T. Fleming, M. D. Galsky, W. R. Berry, et al. “Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.” Ann Oncol 21, no. 2 (February 2010): 319–24. https://doi.org/10.1093/annonc/mdp323.
       Full Text  Link to Item
    • ElBardissi, Andrew W., Scott E. Regenbogen, Caprice C. Greenberg, William Berry, Alex Arriaga, Donald Moorman, Alan Retik, Andrew L. Warshaw, Michael J. Zinner, and Atul A. Gawande. “Communication practices on 4 Harvard surgical services: a surgical safety collaborative.” Ann Surg 250, no. 6 (December 2009): 861–65. https://doi.org/10.1097/SLA.0b013e3181afe0db.
       Full Text  Link to Item
    • Sternberg, Cora N., Daniel P. Petrylak, Oliver Sartor, J Alfred Witjes, Tomasz Demkow, Jean-Marc Ferrero, Jean-Christophe Eymard, et al. “Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.” J Clin Oncol 27, no. 32 (November 10, 2009): 5431–38. https://doi.org/10.1200/JCO.2008.20.1228.
       Full Text  Link to Item
    • Abbett, Sarah K., Deborah S. Yokoe, Stuart R. Lipsitz, Angela M. Bader, William R. Berry, Elise M. Tamplin, and Atul A. Gawande. “Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection.” Infect Control Hosp Epidemiol 30, no. 11 (November 2009): 1062–69. https://doi.org/10.1086/644757.
       Full Text  Link to Item
    • Arriaga, Alexander F., Robert T. Lancaster, William R. Berry, Scott E. Regenbogen, Stuart R. Lipsitz, Haytham M. A. Kaafarani, Andrew W. Elbardissi, et al. “The better colectomy project: association of evidence-based best-practice adherence rates to outcomes in colorectal surgery.” Ann Surg 250, no. 4 (October 2009): 507–13. https://doi.org/10.1097/SLA.0b013e3181b672bc.
       Full Text  Link to Item
    • Weiser, Thomas G., Martin A. Makary, Alex B. Haynes, Gerald Dziekan, William R. Berry, Atul A. Gawande, and Atul A. Safe Surgery Saves Lives Measurement and Study Groups. “Standardised metrics for global surgical surveillance.” Lancet 374, no. 9695 (September 26, 2009): 1113–17. https://doi.org/10.1016/S0140-6736(09)61161-2.
       Full Text  Link to Item
    • Galsky, M. D., K. Simon, G. Sonpavde, T. E. Hutson, M. Fleming, G. V. Kondagunta, and W. Berry. “Ketoconazole retains activity in patients with docetaxel-refractory prostate cancer.” Ann Oncol 20, no. 5 (May 2009): 965–66. https://doi.org/10.1093/annonc/mdp199.
       Full Text  Link to Item
    • Haynes, Alex B., Thomas G. Weiser, William R. Berry, Stuart R. Lipsitz, Abdel-Hadi S. Breizat, E Patchen Dellinger, Teodoro Herbosa, et al. “A surgical safety checklist to reduce morbidity and mortality in a global population.” N Engl J Med 360, no. 5 (January 29, 2009): 491–99. https://doi.org/10.1056/NEJMsa0810119.
       Full Text  Link to Item
    • Panknin, H. T., A. B. Haynes, T. G. Weiser, W. R. Berry, S. R. Lipsitz, A. H. Breizat, E. P. Dellinger, et al. “Safe surgery: A WHO checklist reduces the complication rate.” Hygiene + Medizin 34, no. 4 (January 1, 2009): 157–60.
    • Sonpavde, Guru, Thomas E. Hutson, William R. Berry, Kristi A. Boehm, and Lina Asmar. “Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy.” Clin Genitourin Cancer 6, no. 2 (September 2008): 134–37. https://doi.org/10.3816/CGC.2008.n.023.
       Full Text  Link to Item
    • Weiser, Thomas G., Scott E. Regenbogen, Katherine D. Thompson, Alex B. Haynes, Stuart R. Lipsitz, William R. Berry, and Atul A. Gawande. “An estimation of the global volume of surgery: a modelling strategy based on available data.” Lancet 372, no. 9633 (July 12, 2008): 139–44. https://doi.org/10.1016/S0140-6736(08)60878-8.
       Full Text  Link to Item
    • Hutson, Thomas E., Svetislava Vukelja, Daniel Atienza, Sanjay Awasthi, Robert Delaune, Margaret Deutsch, Philip Y. Dien, et al. “Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium.” Invest New Drugs 26, no. 2 (April 2008): 151–58. https://doi.org/10.1007/s10637-007-9111-2.
       Full Text  Link to Item
    • Sonpavde, Guru, Kim N. Chi, Thomas Powles, Christopher J. Sweeney, Noah Hahn, Thomas E. Hutson, Matthew D. Galsky, William R. Berry, and Dov Kadmon. “Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.” Cancer 110, no. 12 (December 15, 2007): 2628–39. https://doi.org/10.1002/cncr.23085.
       Full Text  Link to Item
    • Sonpavde, Guru, Ana Aparicio, Israel Guttierez, Kristi A. Boehm, Thomas E. Hutson, William R. Berry, Lina Asmar, and Daniel D. von Hoff. “Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy.” Clin Genitourin Cancer 5, no. 7 (December 2007): 457–59. https://doi.org/10.3816/CGC.2007.n.036.
       Full Text  Link to Item
    • Fizazi, Karim, Aurelie Le Maitre, Gary Hudes, William R. Berry, W Kevin Kelly, Jean-Christophe Eymard, Christopher J. Logothetis, Jean-Pierre Pignon, Stefan Michiels, and Stefan Meta-analysis of Estramustine in Prostate Cancer (MECaP) Trialists’ Collaborative Group. “Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.” Lancet Oncol 8, no. 11 (November 2007): 994–1000. https://doi.org/10.1016/S1470-2045(07)70284-X.
       Full Text  Link to Item
    • Berry, William, Maha Elkordy, Mark O’Rourke, Myrna Khan, and Lina Asmar. “Results of a phase II study of weekly paclitaxel plus carboplatin in advanced carcinoma of unknown primary origin: a reasonable regimen for the community-based clinic?” Cancer Invest 25, no. 1 (February 2007): 27–31. https://doi.org/10.1080/07357900601130656.
       Full Text  Link to Item
    • Berry, William. “I'm a surgeon, not a teammate.” J Med Pract Manage 22, no. 5 (2007): 307–9.
       Link to Item
    • Chittoor, Sreeni, William Berry, David Loesch, Keith Logie, John Fleagle, Stephanie Mull, Kristi A. Boehm, Feng Zhan, and Lina Asmar. “Phase II study of low-dose docetaxel/estramustine in elderly patients or patients aged 18-74 years with hormone-refractory prostate cancer.” Clin Genitourin Cancer 5, no. 3 (December 2006): 212–18. https://doi.org/10.3816/CGC.2006.n.039.
       Full Text  Link to Item
    • Sonpavde, Guru, Thomas E. Hutson, Matthew D. Galsky, and William R. Berry. “Problems with the randomized discontinuation design.” J Clin Oncol 24, no. 28 (October 1, 2006): 4669–70. https://doi.org/10.1200/JCO.2006.08.1026.
       Full Text  Link to Item
    • Berry, William, David Friedland, John Fleagle, Don Jackson, Des Ilegbodu, Kristi A. Boehm, and Lina Asmar. “A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer.” Clin Genitourin Cancer 5, no. 2 (September 2006): 131–37. https://doi.org/10.3816/CGC.2006.n.029.
       Full Text  Link to Item
    • Sonpavde, Guru, Thomas E. Hutson, and William R. Berry. “Systemic chemotherapy for urothelial cancer.” Clin Genitourin Cancer 5, no. 1 (June 2006): 34–42. https://doi.org/10.3816/CGC.2006.n.015.
       Full Text  Link to Item
    • Sonpavde, Guru, Thomas E. Hutson, and William R. Berry. “Hormone refractory prostate cancer: Management and advances.” Cancer Treat Rev 32, no. 2 (April 2006): 90–100. https://doi.org/10.1016/j.ctrv.2005.12.005.
       Full Text  Link to Item
    • Berry, William R. “Systemic therapy for prostate cancer.” N C Med J 67, no. 2 (2006): 154–57.
       Link to Item
    • Berry, William. “Surgical malpractice: myths and realities.” J Med Pract Manage 22, no. 1 (2006): 50–51.
       Link to Item
    • Berry, William R. “Re-induction of hormonal sensitivity in hormone-refractory prostate cancer--fact or fiction?” Nat Clin Pract Oncol 2, no. 4 (April 2005): 180–81. https://doi.org/10.1038/ncponc0136.
       Full Text  Link to Item
    • Berry, W. R., R. De Wit, and W. K. Oh. “Docetaxel in hormone-refractory metastatic prostate cancer.” Drugs 65, no. 16 (January 1, 2005): 2295. https://doi.org/10.2165/00003495-200565160-00004.
       Full Text
    • Berry, William, and Mario Eisenberger. “Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.” Oncologist 10 Suppl 3 (2005): 30–39. https://doi.org/10.1634/theoncologist.10-90003-30.
       Full Text  Link to Item
    • Tannock, Ian F., Ronald de Wit, William R. Berry, Jozsef Horti, Anna Pluzanska, Kim N. Chi, Stephane Oudard, et al. “Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.” N Engl J Med 351, no. 15 (October 7, 2004): 1502–12. https://doi.org/10.1056/NEJMoa040720.
       Full Text  Link to Item
    • Berry, William R., James W. Hathorn, Shaker R. Dakhil, David M. Loesch, Don V. Jackson, Mary Ann Gregurich, Jennifer K. Newcomb-Fernandez, and Lina Asmar. “Phase II randomized trial of weekly paclitaxel with or without estramustine phosphate in progressive, metastatic, hormone-refractory prostate cancer.” Clin Prostate Cancer 3, no. 2 (September 2004): 104–11. https://doi.org/10.3816/cgc.2004.n.020.
       Full Text  Link to Item
    • Beer, Tomasz M., William Berry, Emily M. Wersinger, and Lisa B. Bland. “Weekly docetaxel in elderly patients with prostate cancer: efficacy and toxicity in patients at least 70 years of age compared with patients younger than 70 years.” Clin Prostate Cancer 2, no. 3 (December 2003): 167–72. https://doi.org/10.3816/cgc.2003.n.025.
       Full Text  Link to Item
    • Gregory, Stephanie A., Delvyn C. Case, Linda Bosserman, Debra L. Litwak, William R. Berry, Leonard A. Kalman, Robert J. Belt, and Alan Saven. “Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.” Clin Lymphoma 4, no. 2 (September 2003): 93–98. https://doi.org/10.3816/clm.2003.n.017.
       Full Text  Link to Item
    • Berry, William, Shaker Dakhil, Manuel Modiano, Maryann Gregurich, and Lina Asmar. “Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer.” J Urol 168, no. 6 (December 2002): 2439–43. https://doi.org/10.1097/01.ju.0000035648.32750.00.
       Full Text  Link to Item
    • Berry, W., S. Dakhil, M. A. Gregurich, and L. Asmar. “Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate.” Semin Oncol 28, no. 4 Suppl 15 (August 2001): 8–15. https://doi.org/10.1016/s0093-7754(01)90149-6.
       Full Text  Link to Item
    • Berry, W. “Sugar-free methadone [3].” Pharmaceutical Journal 259, no. 6957 (January 1, 1997): 288.
    • Schiller, J. H., B. Storer, J. Berlin, J. Wittenkeller, M. Larson, L. Pharo, and W. Berry. “Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: A report of high response rates and prolonged survival.” Journal of Clinical Oncology 14, no. 6 (January 1, 1996): 1913–21. https://doi.org/10.1200/JCO.1996.14.6.1913.
       Full Text
    • Buzdar, A. U., L. Esparza, R. Natale, R. Cody, K. Calzone, A. B. Benson, T. Sheehan, and W. Berry. “Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study.” Am J Clin Oncol 17, no. 5 (October 1994): 417–21. https://doi.org/10.1097/00000421-199410000-00012.
       Full Text  Link to Item
    • Berry, W. R., K. W. House, J. T. Lee, P. B. Plagge, M. W. Meshad, and R. Grapski. “Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.” Semin Oncol 19, no. 6 Suppl 15 (December 1992): 33–37.
       Link to Item
    • Graham, S. D., A. Walker, E. B. Cox, J. Laszlo, W. R. Berry, and D. F. Paulson. “Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.” Urology 28, no. 5 (November 1986): 404–8. https://doi.org/10.1016/0090-4295(86)90074-9.
       Full Text  Link to Item
    • Paulson, D. F., R. A. Walker, W. R. Berry, E. B. Cox, and W. Hinshaw. “Vincristine, bleomycin, methotrexate, 5-fluorouracil, and prednisone in metastatic, hormonally unresponsive prostatic adenocarcinoma.” Urology 17, no. 5 (May 1981): 443–45. https://doi.org/10.1016/0090-4295(81)90185-0.
       Full Text  Link to Item
    • Lyles, K. W., W. R. Berry, M. Haussler, J. M. Harrelson, and M. K. Drezner. “Hypophosphatemic osteomalacia: association with prostatic carcinoma.” Ann Intern Med 93, no. 2 (August 1980): 275–78. https://doi.org/10.7326/0003-4819-93-2-275.
       Full Text  Link to Item
    • Myers, L. E., D. F. Paulson, W. R. Berry, E. B. Cox, J. Laszlos, and W. Stanley. “A time-dependent statistical model which relates current clinical status to prognosis: application to advanced prostatic cancer.” J Chronic Dis 33, no. 8 (1980): 491–99. https://doi.org/10.1016/0021-9681(80)90074-0.
       Full Text  Link to Item
    • Paulson, D. F., W. R. Berry, E. B. Cox, A. Walker, and J. Laszlo. “Treatment of metastatic endocrine-unresponsive carcinoma of the prostate gland with multiagent chemotherapy: indicators of response to therapy.” J Natl Cancer Inst 63, no. 3 (September 1979): 615–22. https://doi.org/10.1093/jnci/63.3.615.
       Full Text  Link to Item
    • Wilson, P. W., W. R. Berry, and W. F. Rosse. “Splenectomy in sickle-cell disease.” Ann Intern Med 91, no. 2 (August 1979): 320. https://doi.org/10.7326/0003-4819-91-2-320_1.
       Full Text  Link to Item
    • Berry, W. R., J. Laszlo, E. Cox, A. Walker, and D. Paulson. “Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate.” Cancer 44, no. 2 (August 1979): 763–75. https://doi.org/10.1002/1097-0142(197908)44:2<763::aid-cncr2820440251>3.0.co;2-5.
       Full Text  Link to Item

  • Book Sections

    • Franco, I., D. L. Hepner, W. R. Berry, and A. F. Arriaga. “Fundamentals of managing the operative catastrophe.” In Fundamentals of General Surgery, 321–38, 2018. https://doi.org/10.1007/978-3-319-75656-1_25.
       Full Text
    • Uhlig, P. N., W. R. Berry, E. W. Raboin, J. Brown, J. T. Erskin, A. Hendrich, and D. B. Raemer. “Preventing Complications: New Frontiers of Safety Science in Cardiothoracic Surgery.” In Complications in Cardiothoracic Surgery: Avoidance and Treatment: Second Edition, 1–21, 2009. https://doi.org/10.1002/9781444307580.ch1.
       Full Text

  • Conference Papers

    • Berry, William R., Christopher Michael Pieczonka, Nicholas J. Vogelzang, Lawrence Ivan Karsh, James L. Bailen, Krista Van Velzen, Harini Kandadi, Nadeem Anwar Sheikh, and Shaker R. Dakhil. “Antigen (Ag) spread after sipuleucel-T and correlation with overall survival (OS): A real-world experience.” In Journal of Clinical Oncology, 37:e16504–e16504. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.e16504.
       Full Text
    • Fong, Peter C. C., Margitta Retz, Alexandra Drakaki, Christophe Massard, William R. Berry, Emanuela Romano, Johann S. De Bono, et al. “Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort C of the phase 1b/2 KEYNOTE-365 study.” In Journal of Clinical Oncology, 37:5010–5010. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.5010.
       Full Text
    • Massard, Christophe, Margitta Retz, Peter Hammerer, Fernando Quevedo, Peter C. C. Fong, William R. Berry, Howard Gurney, et al. “Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort B of the phase 1b/2 KEYNOTE-365 study.” In Journal of Clinical Oncology, 37:5029–5029. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.5029.
       Full Text
    • De Giorgi, Ugo, Eleni Efstathiou, William R. Berry, Heather Ann Payne, Katarzyna Madziarska, Katharina Modelska, Xiaowei Guan, Jennifer Sugg, Joyce Leta Steinberg, and Cora N. Sternberg. “A phase III, randomized, double-blind, placebo-controlled study of enzalutamide in men with nonmetastatic castration-resistant prostate cancer: Post-hoc analysis of PROSPER by prior therapy.” In Journal of Clinical Oncology, 37:185–185. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.185.
       Full Text
    • Fong, Peter C. C., Margitta Retz, Alexandra Drakaki, Christophe Massard, William R. Berry, Emanuela Romano, Johann S. De Bono, et al. “Keynote-365 cohort C: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC).” In Journal of Clinical Oncology, 37:171–171. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.171.
       Full Text
    • Massard, Christophe, Margitta Retz, Peter Hammerer, Fernando Quevedo, Peter C. C. Fong, William R. Berry, Howard Gurney, et al. “Keynote-365 cohort b: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC).” In Journal of Clinical Oncology, 37:170–170. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.170.
       Full Text
    • Tucker, Matthew D., Jason Zhu, William R. Berry, Sundhar Ramalingam, Tian Zhang, Michael Roger Harrison, Yuan Wu, Patrick Healy, Daniel J. George, and Andrew J. Armstrong. “Pembrolizumab in men with heavily treated metastatic castration-resistant prostate cancer (mCRPC).” In Journal of Clinical Oncology, 37:172–172. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.172.
       Full Text
    • Koontz, B. F., K. E. Hoffman, P. Healy, D. J. George, M. R. Harrison, T. Zhang, W. R. Lee, et al. “Two Year Outcomes of Short-Term Potent Androgen Blockade and Definitive Radiation for Intermediate to High Risk Localized Prostate Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 102:S100–S100. Elsevier BV, 2018. https://doi.org/10.1016/j.ijrobp.2018.06.256.
       Full Text
    • George, Daniel J., Elisabeth I. Heath, A Oliver Sartor, Guru Sonpavde, William R. Berry, Patrick Healy, Carolyn Winters, et al. “Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP).” In Journal of Clinical Oncology, Vol. 36. AMER SOC CLINICAL ONCOLOGY, 2018.
       Link to Item
    • Koontz, Bridget F., Karen E. Hoffman, Patrick Healy, Daniel J. George, Michael Roger Harrison, Tian Zhang, W Robert Lee, et al. “Phase II trial of 6 months ADT/abiraterone acetate plus prednisone (AAP) and definitive radiotherapy (AbiRT) for men with intermediate to high risk localized prostate cancer.” In Journal of Clinical Oncology, 36:11–11. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.6_suppl.11.
       Full Text
    • Singer, Sara J., George Molina, Zhonghe Li, Wei Jiang, Suliat Nurudeen, Julia G. Kite, Lizabeth Edmondson, Richard Foster, Alex B. Haynes, and William R. Berry. “Relationship Between Operating Room Teamwork, Contextual Factors, and Safety Checklist Performance.” In J Am Coll Surg, 223:568-580.e2, 2016. https://doi.org/10.1016/j.jamcollsurg.2016.07.006.
       Full Text  Link to Item
    • Armstrong, Andrew J., Celestia S. Higano, A Oliver Sartor, Nicholas J. Vogelzang, William R. Berry, David F. Penson, Vahan Kassabian, et al. “Changing characteristics of patients treated with sipuleucel-T (sip-T) over time: Real-world experience from the PROCEED registry.” In Journal of Clinical Oncology, 34:320–320. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.2_suppl.320.
       Full Text
    • Nordquist, Luke T., Neal D. Shore, Johann S. De Bono, Shilpa Gupta, William R. Berry, Silke Gillessen, Glenn Liu, et al. “Objective response of the dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist, VT-464, in patients with CRPC.” In Journal of Clinical Oncology, 34:273–273. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.2_suppl.273.
       Full Text
    • Shore, Neal D., Luke T. Nordquist, Shilpa Gupta, Mark T. Fleming, William R. Berry, Jingsong Zhang, Michael R. Kurman, Joel Robert Eisner, and William R. Moore. “Once-nightly (QD) dual CYP17-Lyase (L) inhibitor / androgen receptor (AR) antagonist VT-464 in patients with CRPC.” In Journal of Clinical Oncology, 34:343–343. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.2_suppl.343.
       Full Text
    • De Bono, Johann Sebastian, Carmel Jo Pezaro, Silke Gillessen, Neal D. Shore, Luke T. Nordquist, Eleni Efstathiou, John C. Araujo, et al. “The oral CYP17-Lyase (L) inhibitor VT-464 in patients with CRPC.” In Journal of Clinical Oncology, 33:187–187. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.7_suppl.187.
       Full Text
    • Nabhan, Chadi, A Oliver Sartor, Matthew R. Cooperberg, Andrew J. Armstrong, Jeffrey L. Vacirca, Raoul S. Concepcion, William R. Berry, et al. “Sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) patients ≥80 years-old: Data from PROCEED.” In Journal of Clinical Oncology, 32:64–64. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.4_suppl.64.
       Full Text
    • Bowman, Kendra G., Goran Jovic, Shawn Rangel, William R. Berry, and Atul A. Gawande. “Pediatric emergency and essential surgical care in Zambian hospitals: a nationwide study.” In J Pediatr Surg, 48:1363–70, 2013. https://doi.org/10.1016/j.jpedsurg.2013.03.045.
       Full Text  Link to Item
    • Berry, William R. “The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer.” In Urology, 65:2–7, 2005. https://doi.org/10.1016/j.urology.2005.03.080.
       Full Text  Link to Item
    • COX, E. B., and W. R. BERRY. “LDH AS A PREDICTOR OF CHEMOTHERAPY RESPONSE AND SURVIVAL IN HORMONE REFRACTORY METASTATIC PROSTATE-CANCER (HRPC).” In Proceedings of the American Association for Cancer Research, 20:414–414. AMER ASSOC CANCER RESEARCH, 1979.
       Link to Item
    • LYLES, K. W., W. R. BERRY, M. R. HAUSSLER, J. M. HARRELSON, and M. K. DREZNER. “TUMOR-INDUCED OSTEOMALACIA - CAUSE OF BONE PAIN IN PATIENTS WITH PROSTATIC-CARCINOMA.” In Clinical Research, 27:A389–A389. SLACK INC, 1979.
       Link to Item
    • BERRY, W. R., J. LASZLO, A. WALKER, and D. PAULSON. “MAJOR PROGNOSTIC FEATURES IN METASTATIC CARCINOMA OF PROSTATE.” In Proceedings of the American Association for Cancer Research, 19:58–58. AMER ASSOC CANCER RESEARCH, 1978.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.